Biofouling · 2016 · 31 citations · 25 references
PharmacyPharmaceuticsPharmacologyAntimicrobial ResistanceDrug DeliveryPharmaceutical TechnologyAntibacterial TherapyAntibiotic ResistanceAntimicrobial BiomaterialsAntimicrobial TherapyCatheter CareCombination Antimicrobial TherapyAntimicrobial Catheter CoatingsCatheter-associated Urinary Tract InfectionsControlled Release ProfilesFluoroquinolone AntibioticsMatrix Drug ReleaseReal-time Shelf-life MonitoringShelf LifeUrinary Tract Infection Antibiotic Therapy
The incidence of catheter associated urinary tract infections (CAUTIs) is increasing worldwide. This study was designed to modify a biomaterial by impregnating a silicone urinary catheter with combination of a macrolide, azithromycin (AZM) and a fluoroquinolone, ciprofloxacin (CIP). Drug release profiles showed slow yet continuous release of antibiotics from catheters for one month. In vitro efficacy testing showed that group B catheters [3% (w v(-1)) CIP + 6% (w v(-1)) AZM] outperformed group A catheters [2% (w v(-1)) CIP + 5% (w v(-1)) AZM] by (1) showing larger zones of inhibition (>31 mm) compared to group A (<28 mm) for up to 30 days against Pseudomonas aeruginosa PAO1; (2) killing adhered bacteria in 24 h compared to 24-48 h in group A; (3) showing longer antimicrobial durability for four weeks; and (4) exhibiting a stable real-time shelf life of one year, suggesting that these catheters can be explored in clinical settings, especially in long-term CAUTI.
25
Cochrane Database of Systematic Reviews
Steve Bell, J. Hill · Cochrane Database of Systematic Reviews · 2003 · 11.3K citations · Full text
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Michael A. Kohanski, Daniel J. Dwyer, Boris Hayete et al. · Cell · 2007 · 3K citations · Full text
Thomas M. Hooton, Suzanne Bradley, Diana D. Cardenas et al. · Clinical Infectious Diseases · 2010 · 2.1K citations · Full text
Public Health, Infectious Disease Control, Infectious Diseases +16